These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 29972075)
1. Skin autofluorescence is associated with high-sensitive cardiac troponin T, a circulating cardiac biomarker, in Japanese patients with diabetes: A cross-sectional study. Yoshioka K Diab Vasc Dis Res; 2018 Nov; 15(6):559-566. PubMed ID: 29972075 [TBL] [Abstract][Full Text] [Related]
2. Advanced glycation end-products, measured as skin autofluorescence, associate with vascular stiffness in diabetic, pre-diabetic and normoglycemic individuals: a cross-sectional study. Birukov A; Cuadrat R; Polemiti E; Eichelmann F; Schulze MB Cardiovasc Diabetol; 2021 Jun; 20(1):110. PubMed ID: 34176469 [TBL] [Abstract][Full Text] [Related]
3. Skin Autofluorescence is a Noninvasive Surrogate Marker for Diabetic Microvascular Complications and Carotid Intima-Media Thickness in Japanese Patients with Type 2 Diabetes: A Cross-sectional Study. Yoshioka K Diabetes Ther; 2018 Feb; 9(1):75-85. PubMed ID: 29177923 [TBL] [Abstract][Full Text] [Related]
4. High-sensitive troponin T and N-terminal pro-B type natriuretic peptide are associated with cardiovascular events despite the cross-sectional association with albuminuria and glomerular filtration rate. Scheven L; de Jong PE; Hillege HL; Lambers Heerspink HJ; van Pelt LJ; Kootstra JE; Bakker SJ; Gansevoort RT; Eur Heart J; 2012 Sep; 33(18):2272-81. PubMed ID: 22740385 [TBL] [Abstract][Full Text] [Related]
5. Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis. Gravning J; Smedsrud MK; Omland T; Eek C; Skulstad H; Aaberge L; Bendz B; Kjekshus J; Mørkrid L; Edvardsen T Am Heart J; 2013 May; 165(5):716-24. PubMed ID: 23622908 [TBL] [Abstract][Full Text] [Related]
6. Skin collagen fluorophore LW-1 versus skin fluorescence as markers for the long-term progression of subclinical macrovascular disease in type 1 diabetes. Sell DR; Sun W; Gao X; Strauch C; Lachin JM; Cleary PA; Genuth S; ; Monnier VM Cardiovasc Diabetol; 2016 Feb; 15():30. PubMed ID: 26864236 [TBL] [Abstract][Full Text] [Related]
7. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure. Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088 [TBL] [Abstract][Full Text] [Related]
8. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults. Bansal N; Katz R; Dalrymple L; de Boer I; DeFilippi C; Kestenbaum B; Park M; Sarnak M; Seliger S; Shlipak M Clin J Am Soc Nephrol; 2015 Feb; 10(2):205-14. PubMed ID: 25605700 [TBL] [Abstract][Full Text] [Related]
9. Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow-up study. Blanc-Bisson C; Velayoudom-Cephise FL; Cougnard-Gregoire A; Helmer C; Rajaobelina K; Delcourt C; Alexandre L; Blanco L; Mohammedi K; Monlun M; Rigalleau V Cardiovasc Diabetol; 2018 Jun; 17(1):82. PubMed ID: 29884175 [TBL] [Abstract][Full Text] [Related]
10. Circulating soluble receptor for advanced glycation end product: Cross-sectional associations with cardiac markers and subclinical vascular disease in older men with and without diabetes. Wannamethee SG; Welsh P; Papacosta O; Ellins EA; Halcox JPJ; Whincup PH; Sattar N Atherosclerosis; 2017 Sep; 264():36-43. PubMed ID: 28759844 [TBL] [Abstract][Full Text] [Related]
11. Sequential N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin Measurements During Albumin Replacement in Patients With Severe Sepsis or Septic Shock. Masson S; Caironi P; Fanizza C; Carrer S; Caricato A; Fassini P; Vago T; Romero M; Tognoni G; Gattinoni L; Latini R; Crit Care Med; 2016 Apr; 44(4):707-16. PubMed ID: 26571184 [TBL] [Abstract][Full Text] [Related]
12. Skin autofluorescence is associated with severity of vascular complications in Japanese patients with Type 2 diabetes. Tanaka K; Tani Y; Asai J; Nemoto F; Kusano Y; Suzuki H; Hayashi Y; Asahi K; Nakayama M; Miyata T; Watanabe T Diabet Med; 2012 Apr; 29(4):492-500. PubMed ID: 21916970 [TBL] [Abstract][Full Text] [Related]
13. Skin autofluorescence as a measure of advanced glycation end product levels is associated with carotid atherosclerotic plaque burden in an elderly population. Jujić A; Östling G; Persson M; Engström G; Nilsson PM; Melander O; Magnusson M Diab Vasc Dis Res; 2019 Sep; 16(5):466-473. PubMed ID: 31064217 [TBL] [Abstract][Full Text] [Related]
14. Association between Subclinical Atherosclerosis Markers and the Level of Accumulated Advanced Glycation End-Products in the Skin of Patients with Diabetes. Ninomiya H; Katakami N; Sato I; Osawa S; Yamamoto Y; Takahara M; Kawamori D; Matsuoka TA; Shimomura I J Atheroscler Thromb; 2018 Dec; 25(12):1274-1284. PubMed ID: 29962379 [TBL] [Abstract][Full Text] [Related]
15. Epicardial fat thickness in stable coronary artery disease: its relationship with high-sensitive cardiac troponin T and N-terminal pro-brain natriuretic peptide. Börekçi A; Gür M; Özaltun B; Baykan AO; Harbalioğlu H; Seker T; Sen Ö; Acele A; Gözükara MY; Kuloğlu O; Koç M; Çayli M Coron Artery Dis; 2014 Dec; 25(8):685-90. PubMed ID: 25004239 [TBL] [Abstract][Full Text] [Related]
16. Multimarker Strategy for Heart Failure Prognostication. Value of Neurohormonal Biomarkers: Neprilysin vs NT-proBNP. Bayes-Genis A; Barallat J; Galán A; de Antonio M; Domingo M; Zamora E; Gastelurrutia P; Vila J; Peñafiel J; Gálvez-Montón C; Lupón J Rev Esp Cardiol (Engl Ed); 2015 Dec; 68(12):1075-84. PubMed ID: 26297179 [TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide, Troponin-T, and Growth-Differentiation Factor 15 in Adult Congenital Heart Disease. Baggen VJ; van den Bosch AE; Eindhoven JA; Schut AW; Cuypers JA; Witsenburg M; de Waart M; van Schaik RH; Zijlstra F; Boersma E; Roos-Hesselink JW Circulation; 2017 Jan; 135(3):264-279. PubMed ID: 27832613 [TBL] [Abstract][Full Text] [Related]
18. Skin autofluorescence associates with vascular calcification in chronic kidney disease. Wang AY; Wong CK; Yau YY; Wong S; Chan IH; Lam CW Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1784-90. PubMed ID: 24876353 [TBL] [Abstract][Full Text] [Related]
19. Association of Advanced Glycation End Products with coronary Artery Calcification in Japanese Subjects with Type 2 Diabetes as Assessed by Skin Autofluorescence. Hangai M; Takebe N; Honma H; Sasaki A; Chida A; Nakano R; Togashi H; Nakagawa R; Oda T; Matsui M; Yashiro S; Nagasawa K; Kajiwara T; Takahashi K; Takahashi Y; Satoh J; Ishigaki Y J Atheroscler Thromb; 2016 Oct; 23(10):1178-1187. PubMed ID: 26961217 [TBL] [Abstract][Full Text] [Related]
20. Skin autofluorescence (a marker for advanced glycation end products) and erectile dysfunction in diabetes. Kouidrat Y; Zaitouni A; Amad A; Diouf M; Desailloud R; Loas G; Lalau JD J Diabetes Complications; 2017 Jan; 31(1):108-113. PubMed ID: 27847146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]